---
title: "Yelp Inc. Stock 12‑Month Price Target Raised to $26.86, Implies 7% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295218285.md"
description: "Yelp Inc.'s 12-month average price target was raised to $26.86 by seven analysts, up from $26.71, implying a 7% upside based on the Aug. 6 closing price. The consensus rating remains 'Hold' among 11 covering analysts, comprising two buys, seven holds, and two sells."
datetime: "2026-08-07T10:21:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295218285.md)
  - [en](https://longbridge.com/en/news/295218285.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295218285.md)
generator: "portal-rs"
---

# Yelp Inc. Stock 12‑Month Price Target Raised to $26.86, Implies 7% Upside

-   According to estimates from 7 analysts, Yelp Inc. stock's average price target has risen from $26.71 to $26.86, with forecasts ranging from $21 to $32 per share
-   Based on the Aug. 6 closing price, the updated target implies approximately 7% potential upside
-   Consensus rating remains at “Hold” across 11 covering analysts, with 2 Buys, 7 Holds and 2 Sells

Explore more price target data and ratings for Yelp Inc. on the , and track all previous and future analyst recommendations for Yelp Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [YELP.US](https://longbridge.com/en/quote/YELP.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Yelp Chief People Officer Amara Carmen disposes of 500 shares worth $11,070](https://longbridge.com/en/news/297955164.md)
- [Yelp (NYSE:YELP) Insider Carmen Amara Sells 500 Shares of Stock](https://longbridge.com/en/news/298032656.md)
- [Apnimed, Inc. reports Q2 results](https://longbridge.com/en/news/298366495.md)
- [Yelp management presents at Goldman Sachs Communacopia & Technology Conference](https://longbridge.com/en/news/297823800.md)
- [Braveheart Bio, Inc. reports Q2 results](https://longbridge.com/en/news/298361396.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**